Literature DB >> 25051518

Biphasic presence of fibrocytes in a porcine hypertrophic scar model.

Taryn E Travis1, Matthew J Mino, Lauren T Moffatt, Neil A Mauskar, Nicholas J Prindeze, Pejhman Ghassemi, Jessica C Ramella-Roman, Marion H Jordan, Jeffrey W Shupp.   

Abstract

The duroc pig has been described as a promising animal model for use in the study of human wound healing and scar formation. However, little is known about the presence and chronology of the fibrocyte cell population in the healing process of these animals. Wounds known to form scar were created on red duroc swine (3" x 3") with a dermatome to a total depth of either 0.06 inches or 0.09 inches. These wounds were allowed to heal completely and biopsies were done at scheduled time points during the healing process. Biopsies were formalin fixed and paraffin embedded for immunohistochemical analysis. Porcine reactive antibodies to CD-45 and procollagen-1 and a human reactive antibody to LSP-1 were used to detect the presence of fibrocytes in immunohistochemistry, an immunocytochemistry. Initial immunohistochemical studies showed evidence of a biphasic presence of fibrocytes. Pigs with 0.06 inches deep wounds showed positive staining for CD-45 and LSP-1 within highly cellular areas at days 2 and 4 after wounding. Additional animals with 0.09 inches deep wounds showed positive staining within similar areas at days 56, 70, and 113 after wounding. There was no immunohistochemical evidence of fibrocytes in skin biopsies taken at days 14, 28, or 42. Procollagen-1 staining was diffused in all samples. Cultured cells were stained for CD-45, LSP-1, and procollagen-1 by immunocytochemistry. These data confirm that fibrocytes are indeed present in this porcine model. We conclude that these cells are present after initial wounding and later during scar formation and remodeling. We believe that this is an evidence of a biphasic presence of fibrocytes, first as an acute response to skin wounding followed by later involvement in the remodeling process, prompted by continued inflammation in a deep partial thickness wound.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25051518      PMCID: PMC4395505          DOI: 10.1097/BCR.0000000000000097

Source DB:  PubMed          Journal:  J Burn Care Res        ISSN: 1559-047X            Impact factor:   1.845


  37 in total

1.  The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ.

Authors:  J Chesney; M Bacher; A Bender; R Bucala
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

2.  Circulating fibrocytes are increased in children and young adults with pulmonary hypertension.

Authors:  M E Yeager; C M Nguyen; D D Belchenko; K L Colvin; S Takatsuki; D D Ivy; K R Stenmark
Journal:  Eur Respir J       Date:  2011-06-23       Impact factor: 16.671

3.  The pivotal role of fibrocytes and mast cells in mediating fibrotic reactions to biomaterials.

Authors:  Paul T Thevenot; David W Baker; Hong Weng; Man-Wu Sun; Liping Tang
Journal:  Biomaterials       Date:  2011-08-23       Impact factor: 12.479

Review 4.  Fibrocytes in health and disease.

Authors:  Erica L Herzog; Richard Bucala
Journal:  Exp Hematol       Date:  2010-03-18       Impact factor: 3.084

5.  Cysteinyl leukotrienes are autocrine and paracrine regulators of fibrocyte function.

Authors:  Kevin M Vannella; Tracy R McMillan; Ryan P Charbeneau; Carol A Wilke; Peedikayil E Thomas; Galen B Toews; Marc Peters-Golden; Bethany B Moore
Journal:  J Immunol       Date:  2007-12-01       Impact factor: 5.422

6.  Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis.

Authors:  Roderick J Phillips; Marie D Burdick; Kurt Hong; Marin A Lutz; Lynne A Murray; Ying Ying Xue; John A Belperio; Michael P Keane; Robert M Strieter
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

Review 7.  Circulating fibrocytes: collagen-secreting cells of the peripheral blood.

Authors:  Timothy E Quan; Shawn Cowper; Sou-Pan Wu; Linda K Bockenstedt; Richard Bucala
Journal:  Int J Biochem Cell Biol       Date:  2004-04       Impact factor: 5.085

8.  Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma.

Authors:  Matthias Schmidt; Guo Sun; Martin A Stacey; Luca Mori; Sabrina Mattoli
Journal:  J Immunol       Date:  2003-07-01       Impact factor: 5.422

9.  Further similarities between cutaneous scarring in the female, red Duroc pig and human hypertrophic scarring.

Authors:  Kathy Q Zhu; Loren H Engrav; Richard N Tamura; Jana A Cole; Pornprom Muangman; Gretchen J Carrougher; Nicole S Gibran
Journal:  Burns       Date:  2004-09       Impact factor: 2.744

Review 10.  Abnormal cell responses and role of TNF-α in impaired diabetic wound healing.

Authors:  Fanxing Xu; Chenying Zhang; Dana T Graves
Journal:  Biomed Res Int       Date:  2013-01-20       Impact factor: 3.411

View more
  12 in total

1.  A polarized multispectral imaging system for quantitative assessment of hypertrophic scars.

Authors:  Pejhman Ghassemi; Taryn E Travis; Lauren T Moffatt; Jeffrey W Shupp; Jessica C Ramella-Roman
Journal:  Biomed Opt Express       Date:  2014-09-02       Impact factor: 3.732

2.  Dyspigmented hypertrophic scars: Beyond skin color.

Authors:  Abdulnaser Alkhalil; Bonnie C Carney; Taryn E Travis; Seid Muhie; Stacy Ann Miller; Jessica C Ramella-Roman; Pehman Ghassemi; Rasha Hammamieh; Marti Jett; Lauren T Moffatt; Jeffrey W Shupp
Journal:  Pigment Cell Melanoma Res       Date:  2019-04-05       Impact factor: 4.693

Review 3.  Hypertrophic scarring: the greatest unmet challenge after burn injury.

Authors:  Celeste C Finnerty; Marc G Jeschke; Ludwik K Branski; Juan P Barret; Peter Dziewulski; David N Herndon
Journal:  Lancet       Date:  2016-10-01       Impact factor: 79.321

4.  Compression therapy affects collagen type balance in hypertrophic scar.

Authors:  Shawn Tejiram; Jenny Zhang; Taryn E Travis; Bonnie C Carney; Abdulnaser Alkhalil; Lauren T Moffatt; Laura S Johnson; Jeffrey W Shupp
Journal:  J Surg Res       Date:  2015-11-05       Impact factor: 2.192

5.  A Translational Animal Model for Scar Compression Therapy Using an Automated Pressure Delivery System.

Authors:  A Alkhalil; S Tejiram; T E Travis; N J Prindeze; B C Carney; L T Moffatt; L S Johnson; J Ramella-Roman; J W Shupp
Journal:  Eplasty       Date:  2015-07-02

6.  Cells from the hematopoietic lineage are only present transiently during healing in a mouse model of non-severe burn injury.

Authors:  Suzanne Rea; Andrew Stevenson; Natalie L Giles; Fiona M Wood; Mark W Fear
Journal:  Stem Cell Res Ther       Date:  2015-07-24       Impact factor: 6.832

7.  Reducing Wound Tension with Undermining or Imbrication-Do They Work?

Authors:  Naveen M Krishnan; Benjamin J Brown; Steven P Davison; Neil Mauskar; Matthew Mino; Marion H Jordan; Jeffrey W Shupp
Journal:  Plast Reconstr Surg Glob Open       Date:  2016-07-13

8.  In-depth examination of hyperproliferative healing in two breeds of Sus scrofa domesticus commonly used for research.

Authors:  Colton H Funkhouser; Liam D Kirkpatrick; Robert D Smith; Lauren T Moffatt; Jeffrey W Shupp; Bonnie C Carney
Journal:  Animal Model Exp Med       Date:  2021-11-22

9.  Matrix Metalloproteinases Are Differentially Regulated and Responsive to Compression Therapy in a Red Duroc Model of Hypertrophic Scar.

Authors:  Taryn E Travis; Pejhman Ghassemi; Nicholas J Prindeze; Lauren T Moffatt; Bonnie C Carney; Abdulnaser Alkhalil; Jessica C Ramella-Roman; Jeffrey W Shupp
Journal:  Eplasty       Date:  2018-01-05

Review 10.  The Vascular Involvement in Soft Tissue Fibrosis-Lessons Learned from Pathological Scarring.

Authors:  Chenyu Huang; Rei Ogawa
Journal:  Int J Mol Sci       Date:  2020-04-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.